New hope for Parkinson's patients struggling with apathy and loss of motivation
Symptom relief
Recruiting now
This study aims to find out if a new oral medication called IRL757 is safe and tolerable for people with Parkinson's disease who also experience apathy—a lack of interest or motivation. About 75 participants will take either the study drug or a placebo (inactive pill) daily for 1…
Phase: PHASE1, PHASE2 • Sponsor: Integrative Research Laboratories AB • Aim: Symptom relief
Last updated Mar 20, 2026 14:47 UTC